Masaru Terauchi

Title: Masaru Terauchi: Innovator in Pharmaceutical Chemistry

Introduction

Masaru Terauchi is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of therapeutic agents for systemic wasting diseases. With a total of 2 patents, Terauchi's work is recognized for its potential impact on medical treatments.

Latest Patents

Terauchi's latest patents include a method for treating systemic wasting diseases through the administration of a 3,8-diaminotetrahydroquinoline derivative. This compound is represented by a specific formula and is designed to provide an effective treatment for conditions such as cachexia. The second patent focuses on a similar derivative that exhibits potent agonistic activity on GHS-R, further emphasizing its therapeutic potential.

Career Highlights

Masaru Terauchi is associated with Zeria Pharmaceutical Co., Ltd., where he has been instrumental in advancing research and development in pharmaceutical innovations. His expertise in creating compounds that target specific medical conditions has positioned him as a key figure in the industry.

Collaborations

Throughout his career, Terauchi has collaborated with notable colleagues, including Takeshi Watanabe and Masaaki Nagasawa. These partnerships have fostered a collaborative environment that enhances the innovation process within the pharmaceutical sector.

Conclusion

Masaru Terauchi's contributions to pharmaceutical chemistry and his innovative patents highlight his role as a leading inventor in the field. His work continues to pave the way for advancements in treatments for systemic wasting diseases.